Literature DB >> 18367523

Surface loop dynamics in adeno-associated virus capsid assembly.

Nina DiPrimio1, Aravind Asokan, Lakshmanan Govindasamy, Mavis Agbandje-McKenna, R Jude Samulski.   

Abstract

The HI loop is a prominent domain on the adeno-associated virus (AAV) capsid surface that extends from each viral protein (VP) subunit overlapping the neighboring fivefold VP. Despite the highly conserved nature of the residues at the fivefold pore, the HI loops surrounding this critical region vary significantly in amino acid sequence between the AAV serotypes. In order to understand the role of this unique capsid domain, we ablated side chain interactions between the HI loop and the underlying EF loop in the neighboring VP subunit by generating a collection of deletion, insertion, and substitution mutants. A mutant lacking the HI loop was unable to assemble particles, while a substitution mutant (10 glycine residues) assembled particles but was unable to package viral genomes. Substitution mutants carrying corresponding regions from AAV1, AAV4, AAV5, and AAV8 yielded (i) particles with titers and infectivity identical to those of AAV2 (AAV2 HI1 and HI8), (ii) particles with a decreased virus titer (1 log) but normal infectivity (HI4), and (iii) particles that synthesized VPs but were unable to assemble into intact capsids (HI5). AAV5 HI is shorter than all other HI loops by one amino acid. Replacing the missing residue (threonine) in AAV2 HI5 resulted in a moderate particle assembly rescue. In addition, we replaced the HI loop with peptides varying in length and amino acid sequence. This region tolerated seven-amino-acid peptide substitutions unless they spanned a conserved phenylalanine at amino acid position 661. Mutation of this highly conserved phenylalanine to a glycine resulted in a modest decrease in virus titer but a substantial decrease (1 log order) in infectivity. Subsequently, confocal studies revealed that AAV2 F661G is incapable of efficiently completing a key step in the infectious pathway nuclear entry, hinting at a possible perturbation of VP1 phospholipase activity. Molecular modeling studies with the F661G mutant suggest that disruption of interactions between F661 and an underlying P373 residue in the EF loop of the neighboring subunit might adversely affect incorporation of the VP1 subunit at the fivefold axis. Western blot analysis confirmed inefficient incorporation of VP1, as well as a proteolytically processed VP1 subunit that could account for the markedly reduced infectivity. In summary, our studies show that the HI loop, while flexible in amino acid sequence, is critical for AAV capsid assembly, proper VP1 subunit incorporation, and viral genome packaging, all of which implies a potential role for this unique surface domain in viral infectivity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18367523      PMCID: PMC2395211          DOI: 10.1128/JVI.02721-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  61 in total

1.  Virus Particle Explorer (VIPER), a website for virus capsid structures and their computational analyses.

Authors:  V S Reddy; P Natarajan; B Okerberg; K Li; K V Damodaran; R T Morton; C L Brooks; J E Johnson
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

2.  A novel method using baculovirus-mediated gene transfer for production of recombinant adeno-associated virus vectors.

Authors:  Kerstin Sollerbrant; Joacim Elmén; Claes Wahlestedt; Joel Acker; Hélene Leblois-Prehaud; Martine Latta-Mahieu; Patrice Yeh; Michel Perricaudet
Journal:  J Gen Virol       Date:  2001-09       Impact factor: 3.891

3.  Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity.

Authors:  Joseph E Rabinowitz; Fabienne Rolling; Chengwen Li; Hervè Conrath; Weidong Xiao; Xiao Xiao; R Jude Samulski
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

4.  The structure of porcine parvovirus: comparison with related viruses.

Authors:  Alan A Simpson; Benoît Hébert; Gail M Sullivan; Colin R Parrish; Zoltán Zádori; Peter Tijssen; Michael G Rossmann
Journal:  J Mol Biol       Date:  2002-02-01       Impact factor: 5.469

5.  Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors.

Authors:  J S Bartlett; R Wilcher; R J Samulski
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

6.  The VP1 N-terminal sequence of canine parvovirus affects nuclear transport of capsids and efficient cell infection.

Authors:  Maija Vihinen-Ranta; Dai Wang; Wendy S Weichert; Colin R Parrish
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

7.  Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer.

Authors:  R W Walters; S M Yi; S Keshavjee; K E Brown; M J Welsh; J A Chiorini; J Zabner
Journal:  J Biol Chem       Date:  2001-03-21       Impact factor: 5.157

8.  Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection.

Authors:  C E Wobus; B Hügle-Dörr; A Girod; G Petersen; M Hallek; J A Kleinschmidt
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

9.  Adeno-associated virus type 2 capsids with externalized VP1/VP2 trafficking domains are generated prior to passage through the cytoplasm and are maintained until uncoating occurs in the nucleus.

Authors:  Florian Sonntag; Svenja Bleker; Barbara Leuchs; Roger Fischer; Jürgen A Kleinschmidt
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

10.  The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity.

Authors:  Anne Girod; Christiane E Wobus; Zoltán Zádori; Martin Ried; Kristin Leike; Peter Tijssen; Jürgen A Kleinschmidt; Michael Hallek
Journal:  J Gen Virol       Date:  2002-05       Impact factor: 3.891

View more
  26 in total

1.  Structural insights into adeno-associated virus serotype 5.

Authors:  Lakshmanan Govindasamy; Michael A DiMattia; Brittney L Gurda; Sujata Halder; Robert McKenna; John A Chiorini; Nicholas Muzyczka; Sergei Zolotukhin; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2013-08-07       Impact factor: 5.103

2.  Evaluating Local and Directional Resolution of Cryo-EM Density Maps.

Authors:  Sriram Aiyer; Cheng Zhang; Philp R Baldwin; Dmitry Lyumkis
Journal:  Methods Mol Biol       Date:  2021

3.  Establishment of a novel cell line for the enhanced production of recombinant adeno-associated virus vectors for gene therapy.

Authors:  Stifani Satkunanathan; Jun Wheeler; Robin Thorpe; Yuan Zhao
Journal:  Hum Gene Ther       Date:  2014-09-11       Impact factor: 5.695

4.  Mutagenesis of adeno-associated virus type 2 capsid protein VP1 uncovers new roles for basic amino acids in trafficking and cell-specific transduction.

Authors:  Jarrod S Johnson; Chengwen Li; Nina DiPrimio; Marc S Weinberg; Thomas J McCown; R Jude Samulski
Journal:  J Virol       Date:  2010-06-23       Impact factor: 5.103

Review 5.  Stimulus-responsive viral vectors for controlled delivery of therapeutics.

Authors:  Mitchell J Brun; Eric J Gomez; Junghae Suh
Journal:  J Control Release       Date:  2017-08-24       Impact factor: 9.776

6.  Structural Insights into Human Bocaparvoviruses.

Authors:  Mario Mietzsch; Shweta Kailasan; Jamie Garrison; Maria Ilyas; Paul Chipman; Kalle Kantola; Mandy E Janssen; John Spear; Duncan Sousa; Robert McKenna; Kevin Brown; Maria Söderlund-Venermo; Timothy Baker; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2017-05-12       Impact factor: 5.103

7.  Human bocavirus capsid structure: insights into the structural repertoire of the parvoviridae.

Authors:  Brittney L Gurda; Kristin N Parent; Heather Bladek; Robert S Sinkovits; Michael A DiMattia; Chelsea Rence; Alejandro Castro; Robert McKenna; Norm Olson; Kevin Brown; Timothy S Baker; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2010-04-07       Impact factor: 5.103

8.  Structural characterization of the dual glycan binding adeno-associated virus serotype 6.

Authors:  Robert Ng; Lakshmanan Govindasamy; Brittney L Gurda; Robert McKenna; Olga G Kozyreva; R Jude Samulski; Kristin N Parent; Timothy S Baker; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

9.  Vector design Tour de Force: integrating combinatorial and rational approaches to derive novel adeno-associated virus variants.

Authors:  Damien Marsic; Lakshmanan Govindasamy; Seth Currlin; David M Markusic; Yu-Shan Tseng; Roland W Herzog; Mavis Agbandje-McKenna; Sergei Zolotukhin
Journal:  Mol Ther       Date:  2014-07-22       Impact factor: 11.454

10.  Structure of neurotropic adeno-associated virus AAVrh.8.

Authors:  Sujata Halder; Kim Van Vliet; J Kennon Smith; Thao Thi Phuong Duong; Robert McKenna; James M Wilson; Mavis Agbandje-McKenna
Journal:  J Struct Biol       Date:  2015-08-31       Impact factor: 2.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.